Stockreport

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer

Agilent Technologies, Inc.  (A) 
Last agilent technologies, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.agilent.com
PDF MSK and Resolution Bioscience (a part of Agilent) investigate clinical utility of the Resolution ctDx Lung in large prospective cohort SANTA CLARA, Calif.--(BUSINESS [Read more]